Hospira, a hospital products and anesthesia drug manufacturer, received an FDA notice for the quality of its devices, according to News and Insight.
After an inspection of Hospira's medical device quality systems in Lake Forest, Ill., the FDA issued a list of 10 objectionable conditions in a Form 483. So far in 2013, the company has sent out 11 device notifications, including recalls and corrections.
Hospira's Clayton, N.C., facility recently resumed producing propofol, and plans to re-launch the drug shortly.
More Articles on Anesthesia:
ASA Opposes Proposed Changes to Opioid Labels by FDA
Dr. Shawn Crook Joins Bothwell Regional Health Center
Hamilton Medical Anesthesia Ventilator Contains Software Problems
After an inspection of Hospira's medical device quality systems in Lake Forest, Ill., the FDA issued a list of 10 objectionable conditions in a Form 483. So far in 2013, the company has sent out 11 device notifications, including recalls and corrections.
Hospira's Clayton, N.C., facility recently resumed producing propofol, and plans to re-launch the drug shortly.
More Articles on Anesthesia:
ASA Opposes Proposed Changes to Opioid Labels by FDA
Dr. Shawn Crook Joins Bothwell Regional Health Center
Hamilton Medical Anesthesia Ventilator Contains Software Problems